The NWHN applauds the court’s decision, but encourages the public to stay vigilant.
The following statement can be attributed to Cynthia A. Pearson, Executive Director of the National Women’s Health Network. Contact: Evita Almassi, email@example.com or 425-749-1886 The FDA announced that it is reviewing its restrictions on mifepristone, a medication used for miscarriage…
Safe and effective FDA-approved abortion pills (aka medication abortion) are now available by mail in several states — without an in-person clinic visit.
We’re calling on the FDA to let pregnant people receive the abortion pill through the mail so that they can get the pill where they take the pill — at home!
The NWHN is warning all women about the health risks of the new “pink pill” – known as flibanserin and branded as Addyi – alleged to boost female libido.
Aggressive promotion of LARCs—or of any method—infringes on reproductive autonomy, and can’t be separated from the broader context of reproductive coercion.